Effect of Intranasal Growth Hormone-Releasing Hormone and Corticotropin-Releasing Hormone Administration on Growth Hormone and Cortisol Release: Improved Unavailability by Means of Sodium- Gly cocholate
- 1 April 1989
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 68 (4) , 821-824
- https://doi.org/10.1210/jcem-68-4-821
Abstract
Several peptide hormones are effective when administered intranasally (in); these include oxytocin, vasopressin, insulin, glucagon, and calcitonin. With regard to GHRH and CRH, previous studies demonstrated that their bioavailability following in administration was very low. In this study we evaluated the serum GH response to 50 μg GHRH iv and to 700 μg GHRH in, the latter given alone and with 5 and 15 mg sodium-glycocholate (SGC), a surfactant, in six normal men. The bioavailability of in GHRH, calculated as net GH secretory area, was very low, and increased to 7% that of iv GHRH when SGC was used. In the same men, 50 μg CRH was administered both iv and in, alone and with 5 and 15 mg SGC. The bioavailability of in CRH, calculated as net cortisol secretory area, was very low and increased to 100% that of iv CRH when 15 mg SGC was used. These data indicate that the efficacy of GHRH and CRH administered in is significantly augmented by SGC.Keywords
This publication has 2 references indexed in Scilit:
- Ability of corticotropin releasing hormone to stimulate cortisol secretion independent from pituitary adrenocorticotropinLife Sciences, 1988
- The effects of intranasal insufflation of growth hormone releasing factor analogie GRF1 – 29 NH2 on growth hormone secretion in children with short statureActa Endocrinologica, 1986